Open AccessEstimation of clinical efficiency of topical combination therapy patients with pyoderma complicated eczema
Author(s) -
В. А. Охлопков,
E. Yu. Zubareva,
Yu. A. Novikov,
М. С. Сукач,
Т. В. Репина,
I. YU. Lekavitchus,
Н.В. Гранкіна
Publication year - 2014
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/0042-4609-2014-90-3-121-127
Subject(s) - medicine , betamethasone , pyoderma , dermatology , mupirocin , combination therapy , methicillin resistant staphylococcus aureus , biology , bacteria , genetics , staphylococcus aureus
The results of direct open-label study of efficacy and portability of combination therapy with topical betamethasone dipropionate and mupirocin are presented. Material and methods. Twenty two patients with pyoderma complicated eczema were treated with ointment for external use (betamethasone dipropionate and mupirocin) 2 times a day for 14 days. Clinical efficacy was assessed by the reliability decrease of index EASI and dermatological symptoms scale index (DSSI). Results. Clinical convalescense was achieved in all patients by the 14th day of therapy. There was a statistically significant decrease in the indices EASI, DSSI. Portability were well. Conclusion. Our study results showed clinical efficacy and portability of topical combination therapy of betamethasone dipropionate and mupirocin in patients with pyoderma complicated eczema.